Mild elevation of BAFF in NASH patients with ANAs was not associated with any significant difference in the degrees of hepatic fibrosis or steatosis between ANA-seropositive and ANA-seronegative NASH patients. The gene discussed is TNFSF13B; the disease is metabolic dysfunction-associated steatohepatitis.